| 產(chǎn)品名稱 | Pagoclone, (+)- - CI 1043 | |||
| 產(chǎn)品貨號 | Axon 1594 CAS [133737-32-3] MF C23H22ClN3O2MW 407.89 Purity: 99% Optical purity: Optically pure Soluble in DMSO Description Subtype selective partial agonist at GABAA receptor, which binds primarily to the α2/α3 subtypes which are responsible for the anti-anxiety effects of these kind of drugs, but has relatively little efficacy at the α1 subtype which produces the sedative and memory loss effects; nonbenzodiazepine anxiolytic References Certificates Categories Extra info JR Atack. The benzodiazepine binding site of GABA(A) receptors as a target for the development of novel anxiolytics. Exp. Opin. Invest. Drugs. 2005, 14(5), 601-618. ? DJ?Nutt. Alcohol alternatives - a goal for psychopharmacology? J. Psychopharmacol. 2006,?20(3), 318–320.? Certificate of Analysis Material Safety Data Sheet CNS Pain & Inflammation GABA-A Unclassified GABAA-α2 and GABAA-α3 agonist Chemical name 2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)isoindolin-1-one Parent CAS No. [133737-32-3] Order Size Unit Price Stock 5 mg €135.00 In Stock | |||
| 產(chǎn)品價格 | 現(xiàn)貨詢價，電話：010-67529703 | |||
| 產(chǎn)品規(guī)格 | ||||
| 產(chǎn)品品牌 | axonmedchem | |||
| 產(chǎn)品概述 | ||||
| 產(chǎn)品詳情 |
Pagoclone, (+)- - CI 1043Axon 1594 CAS [133737-32-3] MF C23H22ClN3O2
Description
Subtype selective partial agonist at GABAA receptor, which binds primarily to the α2/α3 subtypes which are responsible for the anti-anxiety effects of these kind of drugs, but has relatively little efficacy at the α1 subtype which produces the sedative and memory loss effects; nonbenzodiazepine anxiolytic
GABAA-α2 and GABAA-α3 agonist
Chemical name2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)isoindolin-1-one Parent CAS No.[133737-32-3] |
|||
| 產(chǎn)品資料 |
